6 results match your criteria: "University of Copenhagen and Bispebjerg Hospital[Affiliation]"
Global stroke statistics 2023: Availability of reperfusion services around the world.
Int J Stroke
March 2024
Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
Background: Disparities in the availability of reperfusion services for acute ischemic stroke are considerable globally and require urgent attention. Contemporary data on the availability of reperfusion services in different countries are used to provide the necessary evidence to prioritize where access to acute stroke treatment is needed.
Aims: To provide a snapshot of published literature on the provision of reperfusion services globally, including when facilitated by telemedicine or mobile stroke unit services.
Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapy.
Colorectal Dis
December 2020
European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Aim: The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) assesses the health-related quality of life of patients in cancer trials. There are currently no minimally important difference (MID) guidelines for the EORTC QLQ-C30 for colorectal cancer (CRC). This study aims to estimate MIDs for the EORTC QLQ-C30 scales in patients with advanced CRC treated with chemotherapy and enrolled in clinical trials.
View Article and Find Full Text PDFMinimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer.
Head Neck
November 2020
European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Background: We aimed to estimate minimally important difference (MID) for interpreting group-level change over time for European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire core 30 (EORTC QLQ-C30) scores in head and neck cancer.
Methods: Data were derived retrospectively from two published EORTC trials. Clinical anchors were selected using correlation strength and clinical plausibility of the given anchor/QLQ-C30 scale pair.
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.
Clin Trials
December 2018
1 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Article Synopsis
- There is currently a lack of agreement on how to analyze and interpret health-related quality of life and patient-reported outcomes in cancer clinical trials, complicating comparisons and the application of findings in healthcare settings.
- The SISAQOL Consortium was formed to create standardized guidelines for analyzing these outcomes in cancer randomized controlled trials, focusing on key priorities identified through member discussions.
- Their efforts aim to develop clear research objectives, select appropriate statistical methods, and establish best practices for dealing with missing data, with input from a diverse membership that includes patients, regulators, and researchers.
The European Stroke Organisation Guidelines: a standard operating procedure.
Int J Stroke
October 2015
Department of Neurology, Klinikum Frankfurt Höchst, Frankfurt, Germany.
In 2008, the recently founded European Stroke Organisation published its guidelines for the management of ischemic stroke and transient ischemic attack. This highly cited document was translated in several languages and was updated in 2009. Since then, the European Stroke Organisation has published guidelines for the management of intracranial aneurysms and subarachnoidal hemorrhage, for the establishment of stroke units and stroke centers, and recently for the management of intracerebral hemorrhage.
View Article and Find Full Text PDFSkin rejuvenation using intense pulsed light: a randomized controlled split-face trial with blinded response evaluation.
Arch Dermatol
August 2006
Department of Dermatology, University of Copenhagen and Bispebjerg Hospital, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark.
Objective: To evaluate efficacy and adverse effects of intense pulsed light rejuvenation in a homogeneous group of patients.
Design: Randomized controlled split-face trial.
Setting: University dermatology department.